John Rother Statement on IMS Health Report

04-14-2016 Blog PostsPress Release

“Excessive price hikes on prescription drugs drive up spending year after year with no end in sight. Drug makers’ annual habit of demanding a blank check, without reference to any change in value from patients and taxpayers, makes it harder for American families to make ends meet. Ultimately, these price increases make health care more expensive for all of us, even those who don’t use prescription drugs. It’s outrageous.”

How Do We Deal With Rising Drug Costs?

04-12-2016 Blog PostsMediaPress Release

“There is no silver bullet here. We need to balance affordability, access and innovation whether or not Medicare is directly involved in price negotiations. We can only strike that balance when the market has transparency and competition, and purchasers can pay for value.”

John Rother Statement on Reuters Analysis of Prescription Drug Price Increases

04-4-2016 Blog PostsPress Release

“This is further evidence that skyrocketing drug prices are more widespread than a few bad actors. When major drug companies hike prices on common prescription drugs, Americans suffer. Families are forced to decide between paying for prescriptions or paying bills, and that’s wrong.”

Increasing Drug Prices Hurt Patients and Families

03-31-2016 Blog PostsMediaPress Release

While it’s unconscionable that hedge fund pharmaceutical companies like Turing and Retrophin purchase treatments and suddenly raise prices, the current model in which drug companies raise prices year after year is just as bad for patients – and, frankly, unsustainable for our entire health care system.

American Academy of Neurology Joins Campaign for Sustainable Rx Pricing

03-29-2016 Blog PostsPress Release

Today the National Coalition on Health Care Action Fund announced that the American Academy of Neurology (AAN) has officially joined the coalition’s Campaign for Sustainable Rx Pricing. The American Academy of Neurology represents 30,000 members and is dedicated to promoting the highest quality patient-centered neurologic care.

Senate Special Committee on Aging Examines Drug Pricing

03-17-2016 Blog PostsPress Release

“Companies are buying decades-old prescription drugs and jacking up prices on vulnerable patients. It’s unconscionable. We need more transparency and competition in the prescription drug market to protect Americans from this appalling practice.”

FDA to Prioritize Generic Drug Applications

03-15-2016 Blog PostsPress Release

“Recently, the FDA took an important first step in acknowledging the need to introduce more competition by prioritizing generic applications where there is no competition. This effort will give patients better access to affordable treatments,” said John Rother, executive director of the Campaign for Sustainable Rx Pricing.

AARP Joins Campaign for Sustainable Rx Pricing

03-3-2016 Blog PostsMediaPress Release

Today the National Coalition of Health Care announced that AARP has officially joined the coalition’s Campaign for Sustainable Rx Pricing. AARP is a nonprofit, nonpartisan organization, with a membership of nearly 38 million Americans and shares the Campaign’s goal of finding market-based solutions to reverse the trend of high and rising prescription drug prices.

One Thing Presidential Candidates Can Agree On

03-1-2016 Blog PostsPress Release

Seven presidential candidates are still in the race heading into Super Tuesday and all of them are talking about rising prescription drug prices. While they differ in their solutions to this epidemic, candidates on both sides of the aisle agree that drug prices are rising at an unsustainable rate.

AARP Report Finds Dramatic Prescription Price Hikes

02-29-2016 Blog PostsPress Release

“Today’s AARP report provides new evidence that drug companies are raising prescription drug prices on patients indiscriminately. Specialty and branded drugs alike are going up six times faster than inflation. The exorbitant increases make health care more expensive for families, taxpayers, and job creators and put a major strain on federal and state governments. It’s going to take market-based policy solutions to deal with this unsustainable trend.”

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.